Prestige Consumer Healthcare
PBH
237 hedge funds and large institutions have $2.48B invested in Prestige Consumer Healthcare in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 79 increasing their positions, 95 reducing their positions, and 25 closing their positions.
5.45% more ownership
Funds ownership: 120.87% → 126.32% (+5.5%)
8% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 25
1% more capital invested
Capital invested by funds: $2.46B → $2.48B (+$14.8M)
0% more funds holding
Funds holding: 237 → 237 (0)
17% less repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 95
61% less call options, than puts
Call options by funds: $2.63M | Put options by funds: $6.67M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
+$16.8M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$16.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$15.1M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$11.1M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$9.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MRCP
Manor Road Capital Partners
New York
|
-$35M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$15.6M |
| 3 |
Millennium Management
New York
|
-$11.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.66M |
| 5 |
AF
Aristotle Fund
Portland,
Maine
|
-$5.53M |
PBH Hedge Fund Activity: Q3 2018 in Review
237 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2018, worth a combined $2.48B — up 0.6% from $2.46B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new PBH positions and 25 closed out — a net gain of 2 holders — while 79 added to existing stakes and 95 trimmed.
The largest buyer was Dalton, Greiner, Hartman, Maher & Co, opening a new position worth an estimated $16.8M. The largest seller was Manor Road Capital Partners, cutting an estimated $35M.
- 237 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $2.48B of Prestige Consumer Healthcare stock for Q3 2018, up 0.6% quarter-over-quarter.
- 27 funds opened new Prestige Consumer Healthcare positions in Q3 2018 and 25 closed out, a net change of +2 holders.
- The largest Prestige Consumer Healthcare buyer in Q3 2018 was Dalton, Greiner, Hartman, Maher & Co, an estimated $16.8M added.
- The largest Prestige Consumer Healthcare seller in Q3 2018 was Manor Road Capital Partners, an estimated $35M sold.
Based on aggregated 13F filings for Q3 2018.